Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002537787 | SCV003469846 | uncertain significance | Neuronal ceroid lipofuscinosis 7 | 2023-08-30 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 12 of the MFSD8 protein (p.Pro12Leu). This variant is present in population databases (rs749496400, gnomAD 0.007%). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 990259). This variant has not been reported in the literature in individuals affected with MFSD8-related conditions. |
Natera, |
RCV001278245 | SCV001465243 | uncertain significance | Late-infantile neuronal ceroid lipofuscinosis | 2020-08-14 | no assertion criteria provided | clinical testing |